Search -

Displaying 1 - 20 of 63

Sort: Relevancy | Date

News Conference News EuroPCR 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Yael L. Maxwell

June 02, 2025

News Daily News

DCB in STEMI Match DES Through 5 Years: REVELATION

Caitlin E. Cox

March 27, 2024

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Caitlin E. Cox

October 27, 2023

Presentation TCT 2023

TCT 276: Efficacy of the Orsiro stent in percutaneous coronary intervention for hemodialysis patients compared with other stent types.

Presenter: TANINOBU NARUMI

October 25, 2023

Presentation TCT 2023

TCT 185: Safety and Performance Registry for an All-Comers Subject Population with the Limus Eluting Orsiro Mission Stent System Within Daily Clinical Practice: Twelve-Month Results of the BIOFLOW-VIII Registry

Presenter: Georg Nollert

October 25, 2023

Presentation TCT 2023

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

Presenter: Eline Ploumen

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

TCT 669: Impact of ACS on Long-Term Clinical Outcomes After PCI With the Biolimus-Coated BioFreedom Stent or Biodegradable Polymer Sirolimus-Eluting Orsiro Stent: From the SORT OUT IX Trial

Presentation TCT 2023

TCT 669: Impact of Acute Coronary Syndromes on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention With the Biolimus-Coated BioFreedom Stent or Biodegradable Polymer Sirolimus-Eluting Orsiro Stent: From the SORT OUT IX Trial

Presenter: Manijeh Noori

October 24, 2023

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

News Conference News

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

Caitlin E. Cox

March 02, 2022

News Daily News

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

Caitlin E. Cox

September 15, 2021

News Conference News EuroPCR 2021

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

Caitlin E. Cox

May 24, 2021

News Conference News EuroPCR 2021

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

L.A. McKeown

May 19, 2021

News Conference News CRT 2021

BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients

Caitlin E. Cox

March 16, 2021

News Daily News

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

Michael O'Riordan

March 01, 2021

Presentation Cardiovascular Interventions 2020

Structure Impacts Function: Improved Outcomes with the Thin Strut Orsiro Stent

Presenter: James Hermiller

November 13, 2020

News Conference News TCT 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Shelley Wood

October 17, 2020

News Conference News TCT 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

Todd Neale

October 14, 2020

Presentation TCT 2020

TCT 167: Comparison of Stent Expansion Between Xience and Orsiro Stents in Heavily Calcified Coronary Arteries in Cadaver Heart

Presenter: Yu Sato

October 14, 2020

Presentation TCT 2020

TCT 260: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two De Novo Coronary Artery Lesions – BIOFLOW IV: 5 Year Clinical Results

Presenter: Bernhard Witzenbichler

October 14, 2020

Advertisement

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

DCB in STEMI Match DES Through 5 Years: REVELATION

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

TCT 276: Efficacy of the Orsiro stent in percutaneous coronary intervention for hemodialysis patients compared with other stent types.

TCT 185: Safety and Performance Registry for an All-Comers Subject Population with the Limus Eluting Orsiro Mission Stent System Within Daily Clinical Practice: Twelve-Month Results of the BIOFLOW-VIII Registry

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

TCT 669: Impact of Acute Coronary Syndromes on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention With the Biolimus-Coated BioFreedom Stent or Biodegradable Polymer Sirolimus-Eluting Orsiro Stent: From the SORT OUT IX Trial

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

Structure Impacts Function: Improved Outcomes with the Thin Strut Orsiro Stent

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

TCT 167: Comparison of Stent Expansion Between Xience and Orsiro Stents in Heavily Calcified Coronary Arteries in Cadaver Heart

TCT 260: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two De Novo Coronary Artery Lesions – BIOFLOW IV: 5 Year Clinical Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content